Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

C-Section bleeding study reveals key risks and outcomes

NCT ID NCT04833556

Knowledge-focused Sponsor: Mahidol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviewed the medical records of 649 women who had heavy bleeding (at least 1 liter) after a C-section. Researchers looked at how many needed blood transfusions, intensive care, or other treatments. The goal was to better understand what happens to these patients, not to test a new drug or procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

649 people

The number who actually took part.

Started

Apr 2021

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female patients underwent cesarean delivery with estimated blood loss equal or more than 1,000 ml

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients underwent cesarean delivery with estimated blood loss equal or more than 1,000 ml Exclusion Criteria: * Cesarean delivery at less than 24 weeks of gestation * Patient chart that not contained primary outcome data eg. absent of the anesthetic record

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia complication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postpartum Hemorrhage Transfusion Reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia complication Blood transfusion complication Cesarean section complications Postpartum hemorrhage Uterine atony with hemorrhage

Contacts and locations

Locations

  • Faculty of Medicine Siriraj Hospital

    Bangkok, 10700, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.